Clinical Trial Update: Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular Disease (MK-0974-034) [Phase 3]

View source ↗

Summary

Phase 3 trial update for telcagepant (MK-0974) evaluating treatment of migraine in participants with stable vascular disease; study completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Disease
• Migraine Disorders
• Peripheral Vascular Diseases
• Stroke
• Transient Ischemic Attack
• Vascular Diseases

Drugs mentioned

• Telcagepant (telcagepant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Migraine Disorders, Heart Disease | Phase 3 | Status: COMPLETED | Results posted: 2014-09-17